Ticker > Company >

Bajaj Healthcare share price

Bajaj Healthcare Ltd.

NSE: BAJAJHCARE BSE: 539872 SECTOR: Pharmaceuticals & Drugs  64k   472   53

533.90
-50.90 (-8.70%)
NSE: 20 Dec 04:02 PM

Price Summary

Today's High

₹ 578

Today's Low

₹ 530.35

52 Week High

₹ 615

52 Week Low

₹ 263.3

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1686.23 Cr.

Enterprise Value

2015.37 Cr.

No. of Shares

3.16 Cr.

P/E

0

P/B

3.78

Face Value

₹ 5

Div. Yield

0.19 %

Book Value (TTM)

₹  141.16

CASH

2.93 Cr.

DEBT

332.07 Cr.

Promoter Holding

59.19 %

EPS (TTM)

₹  -3.2

Sales Growth

-26.69%

ROE

-4.44 %

ROCE

1.88%

Profit Growth

-122.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-26.69%
3 Year-10.35%
5 Year7.81%

Profit Growth

1 Year-294.76%
3 Year-200.27%
5 Year-238.72%

ROE%

1 Year-4.44%
3 Year12.71%
5 Year19.03%

ROCE %

1 Year1.88%
3 Year11.97%
5 Year18.26%

Debt/Equity

1.1929

Price to Cash Flow

18.27

Interest Cover Ratio

0.4394

CFO/PAT (5 Yr. Avg.)

0.589334721777535

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 59.19 0.00
Jun 2024 67.73 0.00
Mar 2024 67.73 0.00
Dec 2023 67.73 0.00
Sep 2023 67.69 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 15.4025 days.
  • The company has a high promoter holding of 59.19%.

 Limitations

  • The company has shown a poor profit growth of -155.654275531164% for the Past 3 years.
  • The company has shown a poor revenue growth of -10.3472093937081% for the Past 3 years.
  • Company has low Interest coverage ratio of 0.4394.
  • Tax rate is low at 14.0859.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 101.21 108.57 133.9 132.25 133.09
Total Expenditure 82.26 89.04 117.87 107.74 108.57
Operating Profit 18.95 19.54 16.03 24.5 24.52
Other Income 1.22 0.8 6.45 0.85 2.61
Interest 8.26 6.65 6.01 8.44 7.88
Depreciation 6.66 7.35 7.3 6.73 6.81
Exceptional Items 0 0 -44.33 0 0
Profit Before Tax 5.24 6.33 -35.15 10.18 12.45
Tax 0.12 0.8 -3.15 2.16 4.11
Profit After Tax 5.12 5.52 -32 8.03 8.34
Adjusted EPS (Rs) 1.86 2 -11.6 2.91 2.64

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 410.01 656.98 679.89 645.8 473.42
Total Expenditure 361.73 520.62 561.23 534.32 397.08
Operating Profit 48.28 136.37 118.66 111.48 76.33
Other Income 6.53 6.91 1.44 1.59 8.69
Interest 6.63 8.34 12.78 17.68 29.75
Depreciation 12.12 16.12 17.64 17.21 27.62
Exceptional Items 0 0 0 0 -44.33
Profit Before Tax 36.06 118.82 89.68 78.18 -16.68
Tax 10.82 35.71 18.3 14.65 -2.35
Net Profit 25.24 83.11 71.39 43.02 -83.79
Adjusted EPS (Rs.) 9.14 30.11 25.87 23.02 -5.19

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 13.8 13.8 13.8 13.8 13.8
Total Reserves 164.13 244.61 314.69 353.89 264.56
Borrowings 23.58 79.71 66.31 93.66 38.58
Other N/C liabilities 3.82 4.93 4.23 2.71 -15.15
Current liabilities 137.61 182.57 322.07 435.23 402.11
Total Liabilities 342.95 525.63 721.1 899.29 743.27
Assets
Net Block 162.24 208.13 269.74 365.69 252.75
Capital WIP 5.45 57.05 51.98 20.34 4.8
Intangible WIP 0 0 0 1.39 1.81
Investments 5 0 0 0 0
Loans & Advances 0 0 0 0 1.14
Other N/C Assets 1.84 2.12 1.07 9.84 78.21
Current Assets 168.42 258.33 398.31 502.04 404.54
Total Assets 342.95 525.63 721.1 899.29 743.27
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 36.06 118.82 89.68 58.22 -103.87
Adjustment 15.54 24.48 31.47 55.89 170.44
Changes in Assets & Liabilities -21.91 -64.09 -110.84 -124.76 38.51
Tax Paid -9.12 -35.65 -9.63 -11.54 -12.79
Operating Cash Flow 20.57 43.56 0.69 -22.19 92.29
Investing Cash Flow -27.56 -108.93 -74.8 -93.43 -11.24
Financing Cash Flow 3.28 75.46 61.85 131.37 -96.6
Net Cash Flow -3.7 10.08 -12.27 15.75 -15.55

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 67.69 67.73 67.73 67.73 59.19
anil champalal jain 5.26 5.30 5.30 5.30 4.63
babita sajankumar bajaj 5.45 5.45 5.45 5.45 4.76
bajaj health & nutritions... 0.87 0.87 0.87 0.87 0.76
bansal pharma limited 0.22 0.22 0.22 0.22 0.19
namrata bajaj 5.91 5.91 5.91 5.91 5.17
nihita sajankumar bajaj 5.87 5.87 5.87 5.87 5.13
padma anil jain 1.10 1.10 1.10 1.10 0.96
s k r bajaj huf 7.83 7.83 7.83 7.83 6.84
sajankumar rameshwarlal b... 35.19 35.19 35.19 35.19 30.75
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 32.31 32.27 32.27 32.27 40.81
hdfc mutual fund - hdfc p... - - - - 1.31
llp 0.22 0.07 0.12 0.25 1.14
vls finance ltd 2.34 2.01 2.04 2.04 1.32
maa sharda distributors p... 6.17 6.22 6.11 6.10 -
hetal chetan mehta - 1.11 - - -

Ratings & Research Reports

Company Presentations

Company News

Bajaj Healthcare entering into definitive CDMO contract with UK/EU based companies 9 Dec, 6:31 PM Bajaj Healthcare gets TGA’s approval for API Manufacturing Site in Gujarat 7 Dec, 12:05 PM Bajaj Healthcare enters into development and supply agreement with European Entity 23 Sep, 2:11 PM Bajaj Healthcare informs about newspaper publication 27 Aug, 3:57 PM Bajaj Healthcare - Quaterly Results 14 Aug, 6:57 PM Bajaj Healthcare - Quaterly Results 24 May, 9:48 PM Bajaj Healthcare - Quaterly Results 24 May, 9:48 PM Bajaj Healthcare informs about clarification on increase in volume of shares 15 Apr, 5:11 PM Bajaj Healthcare informs about trading window closure 28 Mar, 5:16 PM Bajaj Healthcare informs about business updates 28 Feb, 3:06 PM Bajaj Healthcare enters into definitive CDMO agreement with UK/EU based customers 28 Feb, 1:00 PM Bajaj Healthcare - Quaterly Results 9 Feb, 8:07 PM Bajaj Healthcare - Quaterly Results 9 Feb, 8:07 PM Bajaj Healthcare informs about disclosures 17 Nov, 12:18 PM Bajaj Healthcare informs about earning updates 13 Nov, 4:06 PM Bajaj Healthcare commissions Alkaloid Extraction Plant in Vadodara 19 Oct, 9:18 AM Bajaj Healthcare completes construction of Alkaloid extraction Plant at Vadodara Unit 14 Oct, 11:39 AM Bajaj Healthcare gets EIR from USFDA for API manufacturing facility in Gujarat 14 Sep, 9:37 AM Bajaj Healthcare informs about newspaper advertisement 8 Sep, 4:56 PM Bajaj Healthcare informs about earning updates 16 Aug, 10:09 AM Bajaj Healthcare - Quaterly Results 14 Aug, 12:00 PM Bajaj Healthcare - Quaterly Results 14 Aug, 12:00 PM Bajaj Healthcare - Quaterly Results 30 May, 7:58 PM Bajaj Healthcare - Quaterly Results 30 May, 7:58 PM Bajaj Healthcare - Quaterly Results 13 Feb, 5:48 PM Bajaj Healthcare - Quaterly Results 13 Feb, 5:48 PM Bajaj Healthcare informs about disclosure 14 Dec, 4:52 PM Bajaj Healthcare commences trial runs for Opium Processing Business 23 Nov, 3:47 PM Bajaj Healthcare informs about disclosure 21 Nov, 12:28 PM USFDA completes pre-approval inspection at Bajaj Healthcare’s API facility in Gujarat 18 Nov, 12:25 PM Bajaj Healthcare - Quaterly Results 11 Nov, 12:00 PM Bajaj Healthcare - Quaterly Results 11 Nov, 12:00 PM Bajaj Healthcare informs about press release 3 Sep, 3:28 PM Bajaj Healthcare - Quaterly Results 12 Aug, 6:06 PM Bajaj Healthcare - Quaterly Results 12 Aug, 6:06 PM Bajaj Healthcare informs about clarification 1 Aug, 5:06 PM Bajaj Healthcare informs about business updates 13 Jul, 10:48 AM Bajaj Healthcare forays into highly regulated- Opiate Processing Business for GOI 13 Jul, 9:20 AM Bajaj Healthcare - Quaterly Results 17 May, 6:06 PM Bajaj Healthcare - Quaterly Results 17 May, 6:06 PM Bajaj Healthcare to resume commercial production of Citicoline Sodium 11 May, 3:18 PM Bajaj Healthcare launches Magnesium L-Threonate in Nutraceutical segment 23 Feb, 12:57 PM Bajaj Healthcare informs about business update 23 Feb, 11:27 AM Bajaj Healthcare informs about outcome of board meeting 28 Jan, 4:34 PM Bajaj Healthcare informs about business updates 24 Nov, 11:04 AM Bajaj Healthcare informs about press release 20 Sep, 10:17 AM Bajaj Healthcare informs about proceedings of postal ballot 18 Sep, 3:03 PM Bajaj Healthcare informs about newspaper publication 9 Sep, 5:06 PM Bajaj Healthcare informs about AGM 9 Sep, 9:49 AM Bajaj Healthcare informs about annual report 8 Sep, 12:55 PM

Bajaj Healthcare Stock Price Analysis and Quick Research Report. Is Bajaj Healthcare an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Bajaj Healthcare and its performance over the period of time. Bajaj Healthcare stock price today is Rs 533.9.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Bajaj Healthcare cash from the operating activity was Rs 92.2944 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Bajaj Healthcare has a Debt to Equity ratio of 1.1929 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Bajaj Healthcare , the EPS growth was -122.5501 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Bajaj Healthcare has OPM of 16.1238516752324 % which is a good sign for profitability.
     
  • ROE: Bajaj Healthcare have a poor ROE of -4.4351 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Bajaj Healthcare is Rs 533.9. One can use valuation calculators of ticker to know if Bajaj Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Bajaj Healthcare
X